About Repertoire Immune Medicines
Repertoire Immune Medicines is a biotechnology company dedicated to creating treatments for diseases based on the power of the human T cell repertoire to eliminate cancer cells, target pathogens and regulate immune function in autoimmune disease.
Our proprietary DECODE platform is designed to provide a comprehensive understanding of the full repertoire of interactions between T cell receptors and their antigen targets that take place when diseased cells are present. This complex and intricate biological process is known as the immune synapse. We believe the ability to decipher these interactions represents one of the greatest opportunities for innovation in medical science.
Repertoire's team operates from sites in Cambridge, Massachusetts and Zurich, Switzerland and uses its DECODE technology to rationally design treatments for cancers, autoimmune disorders and infectious diseases.
To learn more about Repertoire Immune Medicines, please visit our website: www.repertoire.com.
|
|
|
51-200 employees
View all Repertoire Immune Medicines employees
|
|
Biotechnology
|
|
Cambridge, MA, US
|
|
2020
|
Repertoire Immune Medicines Alternatives
Frequently Asked Questions about Repertoire Immune Medicines
The decision makers in Repertoire Immune Medicines are Amy Grunbeck Perea, Arthur Hurwitz, Anthony Coyle, etc. Click to Find Repertoire Immune Medicines decision makers emails.
Repertoire Immune Medicines Staff Directory
Search Repertoire Immune Medicines Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
